News Focus
News Focus
icon url

Luckytouch

02/20/20 3:38 PM

#282539 RE: Rdunn88 #282534

I believe we are well positioned going forward with our Brillicidin platform. It has been trial and error and when a decision is made tp proceed with one set of studies then other pursuits get back burnered. I am not going to woulda, coulda and shoulda and grind on Leo as a horrible person. With little money he as completed multiple trials, P1, POC and P2b all with vey large markets before us. He has always had a very bold vision for ctix/ipix and he hasn’t wavered. I do not waver in my belief in IPIX and it’s management and alliances with BDD Evonik and those who counsel our company. My time spent on this board is greatly shortened by clicking through the negative posts that come from a very dark place and offer me nothing. Anytime I have invested and I soured on a poorly performing investment I have sold, walked away and never looked back. I would never check the price or think of posting on my soured investment. There is simply no point in it and I don’t understand that thinking. Good luck to those who stand tall, TD, Farrell, Boo, Lil K, cos, Karen, Bradford etc. Patience.
icon url

Lemoncat

02/20/20 4:35 PM

#282546 RE: Rdunn88 #282534

That's what LocustWalk is here to do.

1. Have access and connections that Leo Ehrlich does not have.

This is going to get IPIX a better deal than Leo can wrangle himself.

2. Convince Leo that the drugs aren't worth as much as he thinks they are so that he actually signs the best deal LW can get.

The AS deal was a sobering moment for both Leo and shareholders but I suspect he still needs guidance as to what a good deal constitutes.

Let's hope they get it done quick so we can get B-UC and Kevetrin back in the clinic for the big bucks!

Go IPIX!